Xin He

Title: Innovations by Inventor Xin He

Introduction

Xin He is a prominent inventor based in Philadelphia, PA (US). He has made significant contributions to the field of cancer research, particularly in the development of innovative methods for retrieving tumor-related antibodies and antigens. With a total of 2 patents, his work is paving the way for advancements in targeted cancer therapies.

Latest Patents

Xin He's latest patents include groundbreaking inventions that focus on the retrieval of tumor-related antibodies and antigens. One of his notable inventions is a method for Sequential Tumor-related Antibody and antigen Retrieving (STAR). This method efficiently identifies potent antibodies that can specifically bind to tumor-related antigens on the surface of tumor cells. Another significant patent involves a CAR T system that targets CD13, which is designed to treat acute myeloid leukemia. Additionally, he has developed a CAR T system and ADC that targets CDH17, aimed at treating neuroendocrine tumors and other types of tumors expressing this antigen, while maintaining tolerable toxicities.

Career Highlights

Xin He is affiliated with the University of Pennsylvania, where he conducts his research and develops his innovative solutions. His work is characterized by a strong focus on improving cancer treatment methodologies through advanced biotechnological approaches.

Collaborations

Xin He collaborates with esteemed colleagues, including Xianxin Hua and Xuyao Zhang, who contribute to his research endeavors and help enhance the impact of his inventions.

Conclusion

Xin He's contributions to cancer research through his innovative patents are significant and hold promise for future advancements in targeted therapies. His work exemplifies the potential of scientific innovation in addressing critical health challenges.